BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 19/11/2024

FDA Clears JESDUVROQ (daprodustat) Tablets for Approval

The FDA has determined that JESDUVROQ tablets in various strengths were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions.

Source: Federal Register — Food and Drug AdministrationOpen original release →